Evidence map›Paper›PMID 26467470›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2016

Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

M Waterhouse, H A Risch, C Bosetti, K E Anderson, G M Petersen, W R Bamlet, M Cotterchio, S P Cleary, T I Ibiebele, C La Vecchia and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

M WaterhouseDivision of Population Health, QIMR Berghofer Medical Research Institute, Herston Centre for Research Excellence in Sun and Health, Queensland University of Technology, Kelvin Grove, Australia.
H A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, USA.
C BosettiDepartment of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
K E AndersonDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis.
G M PetersenDepartment of Health Sciences Research, Mayo Clinic, Rochester, USA.
W R BamletDepartment of Health Sciences Research, Mayo Clinic, Rochester, USA.
M CotterchioPrevention and Cancer Control, Cancer Care Ontario, Toronto Dalla Lana School of Public Health, University of Toronto, Toronto.
S P ClearyLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto Department of Surgery, University of Toronto, Toronto, Canada.
T I IbiebeleDivision of Population Health, QIMR Berghofer Medical Research Institute, Herston.
C La VecchiaDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
H G SkinnerTruven Health Analytics, Durham.
L StrayerDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis.
P M BracciDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA.
P MaisonneuveDivision of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.
H B Bueno-de-MesquitaNational Institute for Public Health and the Environment, Bilthoven Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK.
W ZatońskiDepartment of Epidemiology, The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology,Warsaw, Poland.
L LuDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, USA.
H YuEpidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.
K Janik-KoncewiczDepartment of Epidemiology, The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology,Warsaw, Poland.
J PoleselEpidemiology and Biostatistics Unit, CRO Aviano National Cancer Institute, IRCCS, Aviano, Italy.
D SerrainoEpidemiology and Biostatistics Unit, CRO Aviano National Cancer Institute, IRCCS, Aviano, Italy.
R E NealeDivision of Population Health, QIMR Berghofer Medical Research Institute, Herston Centre for Research Excellence in Sun and Health, Queensland University of Technology, Kelvin Grove, Australia.
Pancreatic Cancer Case-Control Consortium (PanC4)

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
NCI NIH HHS P30 CA015083
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26467470
PMCPMC4701119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.